Navigation Links
FDA Approves Genetic Test for Breast Cancer
Date:7/8/2008

Kit will help identify which patients are most likely to respond to Herceptin

TUESDAY, July 8 (HealthDay News) -- A genetic test to determine whether a breast cancer patient is likely to respond to treatment with the drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug Administration.

The SPOT-Light HER2 CISH kit helps calculate how many copies of the HER2 gene, which regulates the growth of cancer cells, are in tumor tissue. A healthy breast cell should have two copies of the HER2 gene, but patients with breast cancer may have many more. Since the gene signals cells when to grow, divide and make repairs, too many copies may cause cells to grow and divide too rapidly.

The drug Herceptin targets HER2 protein, helping stop the growth of such cancer cells in breast cancer patients overproducing that particular protein.

"When used with other clinical information and laboratory tests, this test can provide health care professionals with additional insight on treatment decisions for patients with breast cancer," Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health, said in an agency news release.

The SPOT-Light test counts HER2 genes through a chemically stained sample of removed tumor observed under a standard microscope. Previous tests required more expensive and complex fluorescent microscopes. The SPOT-Light also allows labs to store the tissue for later reference, a feature not possible with previously available tests.

The Invitrogen Corp., of Carlsbad, Calif., produces SPOT-Light. San Francisco-based Genentech manufactures Herceptin.

More information

The National Cancer Institute has more about Herceptin.



-- Kevin McKeever




'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Michigan ... meeting in Lapeer on , June 11th. , Meeting ... Location: Lapeer Regional Medical Center,     Conference Room 5 (Lower ... These meetings are designed to assist people with lupus ... one another, and to get a better understanding of ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... Heritage Woods of Gurnee , a BMA ... hosting Breakfast and Bingo at 8:30 a.m. on Friday, ... 3775 Grand Ave. in Gurnee, Illinois, serves older adults ... some help to maintain their independence. , "Come and ... says Tammy Temaner-Rosas, Director of Marketing for Heritage Woods ...
(Date:5/20/2013)... May 20, 2013 When people ... not always to become a celebrity. New Jersey ... 2013 ABC News report (“Chris Christie Says Lap ... clear that the surgery was not done so ... gain celebrity status as a former lap band ...
(Date:5/20/2013)... 20, 2013 In order to prepare for ... wellness team from DrSmartphoneMD launched an article series to raise ... The series launched with the precautions that need ... the DrSmartphoneMD program are not one of the 3.5 million ... more than 90% of all skin cancer cases are associated ...
Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Combat Skin Cancer In Summer Months 2
... , SAN FRANCISCO, Dec. 16 ... software and professional services solutions for the healthcare industry, ... division. Quantros has named software industry veteran Michael Tulloch, ... work from the company,s new Marlborough, MA office. , ...
... Boston University School of Medicine,s (BUSM) Pulmonary Center has ... Heart, Lung, and Blood Institute to derive stem cells ... Darrell Kotton, MD, associate professor of medicine and ... medicine, are the principal investigators of this new grant ...
... A ... impact on employee presenteeism and bottom line benefits. , ... Minneapolis, MN (PRWEB) December 16, 2009 -- A ... employee participation in health and wellness programs by implementing an incentive program. ...
... Two million screenings conducted through national AAD program ... from melanoma, the deadliest form of skin cancer, almost every ... That,s why thousands of dermatologists across the country offer free ... of Dermatology,s (AAD) National Melanoma/Skin Cancer Screening Program. The program ...
... ... the world,s largest online community for physicians, today announced the ... MD Social Media Conversations ." The report examines physician ... complete analysis of a variety of topics, including the therapies ...
... , , WILMINGTON, Delaware, December ... to outsource their accurate forecast models,for new and inmarket ... solutions to various players. These pharma,forecasting solutions are designed ... These have a substantial impact on pricing, launch, product ...
Cached Medicine News:Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3
(Date:5/20/2013)... DIEGO , May 20, 2013  Volcano Corporation ... manufacturer of precision guided therapy tools designed to enhance ... disease, today announced it will highlight its efforts to ... its Fractional Flow Reserve (FFR) and iFR ® ... and educational presentations and events at EuroPCR 2013 in ...
(Date:5/20/2013)... , May 20, 2013 The Board ... subsidiary companies include OMNIlife science®, Inc., Enztec, Ltd., and ... their Board.  Guy Mayer , ... Chairman of the Board of Directors and David Johnson, ... a director. Before joining OSI as ...
(Date:5/20/2013)... , May 20, 2013  Upsher-Smith Laboratories, ... development of new treatments for diseases of the ... its newly designed website, upsher-smith.com . The ... narratives.  As part of the company,s mission statement ... branding campaign centers around people with a story ...
Breaking Medicine Technology:Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Upsher-Smith Introduces Newly Redesigned Corporate Website 2
... , WALTHAM, Mass., Dec. ... research and advisory firms for pharmaceutical and healthcare issues, ... metastatic colorectal cancer treatment, Roche/Chugai,s Avastin will face increasing ... France and Spain. , The new Special European Physician ...
... Genoptix, Inc. (Nasdaq: GXDX ), a specialized laboratory ... Bank 2009 MedTools Investor Conference to be held at the ... , Genoptix,s EVP and COO, Sam Riccitelli, will be ... 2009. He will provide an overview of the Company,s ...
Cached Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
... membrane parasite soluble lysate ... as antigen. Since this ... than the recombinant kit, ... use two ELISA techniques ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
... The dual-electrode SPL defibrillator lead ... design, offering the flexibility and ... Designed for the physician who ... shocking coils, the SPL lead ...
... The Medtronic Subcutaneous Lead ... implanted subcutaneously with the use ... Model 6996T. Improved SQ design ... DFTs, a fast and easy ...
Medicine Products: